Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699420 | Clinical Oncology | 2010 | 5 Pages |
Abstract
Although continuous research is necessary to identify patients who can be managed safely and palliated without WBRT, we feel that a model of the BSBM unfavourable group (Karnofsky performance status <80, uncontrolled primary tumour and presence of extracranial metastases) and no intent to treat systemically might form a basis for validation in other large databases. The triple-negativity criterion was not superior for predicting poor prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Nieder, A. Pawinski, M. Molls,